Apixaban

AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation

Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

Anticoagulation in Patients With Venous Thromboembolism and Cancer

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Effect of Apiban Therapy on AVF Maturation in ESRD Patients

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Apixaban in Thrombocytopenia

Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

SWITCH: Apixaban vs Vitamin K in HM3

Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation